DI FRANCO, ALESSANDRA

DI FRANCO, ALESSANDRA  

Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 2014 Di Franco A; Guasti D; Mazzanti B; Ercolino T; Francalanci M; Nesi G; Bani D; Forti G; Mannelli M; Valeri A; Luconi M
Effect of liraglutide on proliferation and differentiation of human adipose stem cells 2015 Cantini G; Di Franco A; Samava J; Forti G; Mannucci E; Luconi M
Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell 2012 Baglioni S; Cantini G; Poli G; Francalanci M; Squecco R; Di Franco A; Borgogni E; Frontera S; Nesi G; Liotta F; Lucchese M; Perigli G; Francini F; Forti G; Serio M; Luconi M
Glucagon modulates proliferation and differentiation of human adipose precursors. 2019 Cantini G, Trabucco M, Di Franco A, Mannucci E, Luconi M.
Glycated hemoglobin (HbA1c) measurement in frozen whole blood depends on baseline values of fresh samples. 2013 Liotta L; Di Franco A; Pazzagli M; Luconi M
Is cleaved glucagon-like peptide 1 really inactive? Effects of GLP-1(9-36) on human adipose stem cells. 2017 Cantini, Giulia; DI FRANCO, Alessandra; Mannucci, Edoardo; Luconi, Michaela
Massive Weight Loss Obtained by Bariatric Surgery Affects Semen Quality in Morbid Male Obesity: a Preliminary Prospective Double-Armed Study. 2018 Samavat, J; Cantini, G; Lotti, F; Di Franco, A; Tamburrino, L; Degl'Innocenti, S; Maseroli, E; Filimberti, E; Facchiano, E; Lucchese, M; Muratori, M; Forti, G; Baldi, E; Maggi, M; Luconi, M.
Osteocalcin increase after bariatric surgery predicts androgen recovery in hypogonadal obese males. 2014 Samavat J; Facchiano E; Cantini G; Di Franco A; Alpigiano G; Poli G; Seghieri G; Lucchese M; Forti G; Luconi M
Reply to the "Letter to the Editor" Ma Z-G, Yuan Y-P, Zhang X, Tang Q-Z. SGLT1: A potential target for human ischemic and hypertrophic heart? 2018 Cantini G, Di Franco A, Mannucci E, Luconi M.
Reply to the Letter to the Editor MaZ-G, Yuan Y-P, Zhang X, Tang Q-Z.SGLT1: A potential target for human ischemic and hypertrophic heart? Int J Cardiol (2017) 2018 Cantini G, Di Franco A, Mannucci E, Luconi M.
Searching for classical brown fat in humans: development of a novel human fetal brown stem cell model. 2016 Di Franco, A; Guasti, D; Squecco, R; Mazzanti, B; Rossi, F; Idrizaj, E; Gallego-Escuredo, Jm; Villarroya, F; Bani, D; Forti, G; Vannelli, GB; Luconi, M
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 2017 Di Franco, Alessandra; Cantini, Giulia; Tani, Alessia; Coppini, Raffaele; Zecchi-Orlandini, Sandra; Raimondi, Laura; Luconi, Michaela; Mannucci, Edoardo
The role of metabolic changes in shaping the fate of cancer-associated adipose stem cells 2020 Giulia Cantini, Alessandra Di Franco, Massimo Mannelli, Anthony Scimè, Mario Maggi, Michaela Luconi
The sodium-dependent glucose transporters (SGLT) as a new promising pharmacological target in human ischaemic hearts 2017 Di Franco, A.; Cantini, G.; Raimondi, L.; Mannucci, E.; Luconi, M.
Which is the main molecular target responsible for the cardiovascular benefits in the empa-reg outcome trial? A journey through the kidney, the heart and other interesting places 2016 Luconi, M.; Raimondi, L.; Di Franco, A.; Mannucci, E.